|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0066 USD | 0.00% |
|
-17.50% | -70.00% |
| 02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
| 2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Baudax Bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was USD 11.4 million compared to net loss of USD 12.81 million a year ago. Basic loss per share from continuing operations was USD 3.19 compared to USD 81.16 a year ago.
Basic earnings per share was USD 4.91 compared to basic loss per share of USD 126.87 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -70.00% | 346K | |
| +46.19% | 55.7B | |
| -6.14% | 39.57B | |
| +39.44% | 39.91B | |
| -6.65% | 28.16B | |
| +12.33% | 26.3B | |
| -21.78% | 18.94B | |
| -0.35% | 12.12B | |
| +24.18% | 12.12B | |
| +28.38% | 12.17B |
BAUDAX BIO, INC. 
